Ohio Lawmaker Introduces Bill To Standardize Kratom Regulation

Ohio lawmakers are revisiting how kratom is sold and labeled across the state.

Senator Bill Blessing (R-Colerain Township) recently introduced Senate Bill 299, a proposal designed to set clear standards for the sale of kratom and its related products. The measure seeks to bring consistency to an industry that has grown rapidly in recent years with little formal oversight.

What The Proposal Covers

If passed, SB 299 would establish requirements for testing, labeling, age verification, and product transparency.

The bill would also prohibit synthetic kratom derivatives, such as 7-Hydroxymitragynine (7-OH), while maintaining the legality of natural kratom derived directly from the Mitragyna speciosa plant. According to Senator Blessing, the goal is to ensure that products sold in Ohio are accurately represented and responsibly distributed.

Creating A Framework Instead Of A Ban

Governor Mike DeWine had earlier urged the Ohio Board of Pharmacy to consider classifying kratom compounds under state law. However, following industry input, state leaders appear to be favoring a regulatory approach rather than prohibition.

SB 299 represents a middle ground, allowing responsible vendors to operate legally while setting clear guidelines to prevent mislabeled or altered products.

Industry and Advocacy Perspectives

Organizations such as the Global Kratom Coalition and the American Kratom Association (AKA) have expressed support for the idea of structured regulation.

Both groups advocate for the Kratom Consumer Protection Act (KCPA) model, which requires purity testing, accurate labeling, and consumer access to verified natural products.

The Global Kratom Coalition praised the Ohio proposal for separating natural kratom from synthetic variants, stating that it “sets a responsible standard that other states can follow.”

National Regulatory Context

Ohio’s initiative aligns with actions in other states where lawmakers are establishing clearer consumer safety standards. States such as Arizona, Florida, and Utah have adopted kratom-specific consumer protection acts, while others, like Louisiana, have chosen to regulate synthetic compounds separately.

At the federal level, the Food and Drug Administration (FDA) has emphasized monitoring synthetic kratom derivatives while continuing to assess research on natural kratom’s profile.

What’s Next For Ohio

SB 299 is currently under review by the Ohio Senate’s Health Committee.

If approved, it would establish one of the Midwest’s first statewide frameworks for kratom regulation, ensuring clear labeling, verified sourcing, and restricted sales to minors.

The bill has drawn bipartisan interest as lawmakers seek to balance consumer choice, product integrity, and public confidence.

The Takeaway

Ohio’s evolving conversation on kratom reflects a broader national effort to replace uncertainty with clear rules. While opinions differ on how strict those regulations should be, most stakeholders—lawmakers, health officials, and industry advocates—agree on one point: transparency and consistency are key to protecting both consumers and legitimate businesses.